原发性肝癌发生感染性并发症的危险因素分析

刘洪金; 鲍春梅; 白文林; 李因茵; 荣光华; 陆荫英; 陈艳; 刘泽; 程家敏; 曾珍

doi:10.3969/j.issn.1001-5256.2018.05.021

原发性肝癌发生感染性并发症的危险因素分析

DOI: 10.3969/j.issn.1001-5256.2018.05.021

1. 中国人民解放军第三〇二医院肝脏肿瘤研究与诊疗中心
2. 中国人民解放军第三〇二医院临床医学检验中心

基金项目:

国家自然科学基金资助项目(813722481012487)；军队十二五项目(CWS12J024)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2244
- HTML全文浏览量: 18
- PDF下载量: 402
- 被引次数: 0
出版历程
- 收稿日期: 2017-11-29
- 出版日期: 2018-05-20

Risk factors for infectious complications in primary liver cancer

Liver Tumor Research and Treatment Center, 302 Hospital of PLA

Research funding:

摘要

摘要: 目的探究原发性肝癌发生感染性并发症的相关危险因素。方法收集2016年2月-2017年2月解放军第三〇二医院肝脏肿瘤研究与诊疗中心收治的3034例原发性肝癌患者的临床资料,其中发生感染性并发症297例,未发生感染性并发症2737例,分别随机抽取153例感染患者、46例非感染患者为感染组、非感染组。感染组中男133例,女20例,年龄3475岁,平均（56.41±6.69）岁;非感染组男37例,女9例,年龄4774岁,平均（57.52±11.12）岁。分析可疑危险因素与原发性肝癌发生感染性并发症的关系。计量资料符合正态性分布的数据2组间比较采用t检验,偏态分布的数据2组间比较采用Wilcoxon秩和检验;计数资料2组间比较采用χ2检验,危险因素分析采用多因素logistic回归分析。结果多因素分析结果显示,患者年龄≤60岁（OR=5.048,P<0.001）、乙型肝炎病程长（OR=2.446,P=0.035）、HBV DNA阳性（OR=2.618,P=0.005）、Child-Pugh评分高（OR=0.167、P=0.004）、Alb水平低（...
- 肝肿瘤 /
- 感染 /
- 危险因素 /
- logistic模型
Abstract: Objective To investigate the risk factors for infectious complications in patients with primary liver cancer. Methods A retrospective analysis was performed for the clinical data of 3034 patients with primary liver cancer who were admitted to 302 Hospital of PLA from February 2016 to February 2017, and among these patients, 297 experienced infectious complications and 2737 did not experience infectious complications; 153 patients with infectious complications were enrolled as infection group, and 46 without infectious complications were enrolled as non-infection group. There were 133 male and 20 female patients aged 34-75 years ( mean 56. 41 ± 6. 69 years) in the infection group, and 37 male and 9 female patients aged 47-74 years ( mean 57. 52 ± 11. 12 years) in the non-infection group. The association between possible risk factors and infectious complications in patients with primary liver cancer was analyzed. The t test was used for comparison of normally distributed continuous data between two groups, and the Wilcoxon rank sum test was used for comparison of continuous data with skewed distribution between two groups. The chi-square test was used for univariate analysis, and the multivariate logistic regression analysis was used for multivariate analysis. Results The multivariate logistic regression analysis showed that age ≤60 years ( OR = 5. 048, P <0. 001) , long course of hepatitis B and liver cancer ( OR = 2. 446, P = 0. 035, OR = 0. 433, P = 0. 016) , high HBV DNA ( OR = 2. 618, P =0. 005) , high white blood cell count ( OR = 1. 170, P = 0. 001) , high levels of alpha-fetoprotein ( AFP) ( OR = 0. 470, P = 0. 032) , alkaline phosphatase ( OR = 1. 004, P = 0. 004) , and gamma-glutamyl transpeptidase ( OR = 1. 004, P = 0. 006) , high Child-Pugh score ( OR = 0. 167, P = 0. 004) , low albumin ( OR = 0. 999, P < 0. 001) and cholinesterase ( OR = 0. 834, P < 0. 001) , long prothrombin time ( OR = 1. 299, P = 0. 007) , large maximum tumor diameter ( OR = 0. 389, P < 0. 005) , and presence of portal vein tumor thrombus ( OR =2. 378, P = 0. 018) were independent risk factors for infection in patients with primary liver cancer and HBV infection ( all P < 0. 05) . Conclusion Infection in patients with primary liver cancer is associated with risk factors including age of onset, course of hepatitis B and liver cancer, tumor diameter, portal vein tumor thrombus, HBV DNA and AFP levels, and liver function, which should be taken seriously in clinical practice. Active measures should be adopted to reduce infectious complications.
- liver neoplasms /
- infection /
- risk factors /
- logistic models

HTML全文

参考文献(25)

[1]SU CH, LIN Y, CAI L.Genetic factors, viral infection, other factors and liver cancer:an update on current progress[J].Asian Pac J Cancer Prev, 2013, 14 (9) :4953-4960.

[2]WEI KR, YU X, ZHENG RS, et al.Incidence and mortality of liver cancer in China[J].Chin J Cancer, 2014, 33 (8) :388-394.

[3]ZHAO RR, DENG YD, YUAN H, Epidemiological and clinical features of primary liver cancer:an analysis of 236 patients[J].J Clin Hepatol, 2016, 32 (8) :1538-1542. (in Chinese) 赵荣荣, 邓永东, 袁宏.236例原发性肝癌患者流行病学及临床特点分析[J].临床肝胆病杂志, 2016, 32 (8) :1538-1542.

[4]MORALES-ROMERO J, VARGAS G, GARCIA-ROMAN R.Occult HBV infection:a faceless enemy in liver cancer development[J].Viruses, 2014, 6 (4) :1590-1611.

[5]NG E, MYERS RP, MANUEL D, et al.Hospital stays for hepatitis B or C virus infection or primary liver cancer among immigrants:a census-linked population-based cohort study[J].CMAJ Open, 2016, 4 (2) :e162-e168.

[6]WANG L, ZOLLINGER T, ZHANG J.Association between Helicobacter pylori infection and liver cancer mortality in 67 rural Chinese counties[J].Cancer Causes Control, 2013, 24 (7) :1331-1337.

[7]National Healthand Family Planning Commission of the People's Republic of China.Diagnosis, management, and treatment of hepatocellularcarcinoma (V 2017) [J].J Clin Hepatol, 2017, 33 (8) :1419-1431. (in Chinese) 中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范 (2017年版) [J].临床肝胆病杂志, 2017, 33 (8) :1419-1431.

[8]FU J, WANG H.Precision diagnosis and treatment of liver cancer in China[J].Cancer Lett, 2018, 412 (1) :283-288.

[9]TANG ZY.Discussion on the road of liver cancer prevention and treatment in China[J].Chin J Oncol, 2015, 37 (9) :641-643. (in Chinese) 汤钊猷.试论中国肝癌防治之路[J].中华肿瘤杂志, 2015, 37 (9) :641-643.

[10]ZHANG W, SUN B.Impact of age on the survival of patients with liver cancer:an analysis of 27 255 patients in the SEER database[J].Oncotarget, 2015, 6 (2) :633-641.

[11]PATEL T, DANGELL C, MAHESHWARI S.Impact of age on screening and surveillance for primary liver cancer[J].Am J Gastroenterol, 2006, 101 (4) :768-774.

[12]TJONA S, SINT NICOLAAS J, KWEKKEBOOM J, et al.Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine:an association with C2 monitoring and recipient age[J].Liver Transpl, 2010, 16 (7) :837-846.

[13]WANG M, WANG Y, FENG X, et al.Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas:experience of the Chinese National Cancer Center[J].Int J Infect Dis, 2017, 65:15-21.

[14]WANG X, WANG Z, WU L.Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma[J].BMC Surg, 2016, 16:22.

[15]LEE SD, LEE B, KIM SH, et al.Proposal of new expanded selection criteria using total tumor size and (18) F-fluorodeoxyglucose-positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma:the National Cancer Center Korea criteria[J].World J Transplant, 2016, 6 (2) :411-422.

[16] ZHANG HH, SUN SB, HAN CJ, et al.A 3-year-follow-up study on the prognosis of‘two-route chemotherapy’on liver cancer patients with portal vein tumor thrombus[J].Chin J Epidemiol, 2012, 33 (11) :1181-1183. (in Chinese) 张焕虎, 孙胜波, 韩传吉, 等.双途径化疗对合并门静脉癌栓肝癌患者预后的影响 (3年随访报告) [J].中华流行病学杂志, 2012, 33 (11) :1181-1183.

[17]KOELINK CJ, van HASSELT P, van der PLOEG A, et al.Tyrosinemia type I treated by NTBC:how does AFP predict liver cancer?[J].Mol Genet Metab, 2006, 89 (4) :310-315.

[18]LIU H, XU Y, XIANG J, et al.Targeting alpha-fetoprotein (AFP) -MHC complex with CAR T-cell therapy for liver cancer[J].Clin Cancer Res, 2017, 23 (2) :478-488.

[19]BENEJ M, CAPOV I, SKRICKOVA J, et al.Association of the postoperative white blood cells (WBC) count in peripheral blood after radical surgical treatment of left upper lobe non-small cell lung cancer (NSCLC) with overall survival-single center results[J].Bratisl Lek Listy, 2017, 118 (5) :299-301.

[20]HU G, TUOMILEHTO J, PUKKALA E, et al.Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer[J].Hepatology, 2008, 48 (1) :129-136.

[21]LU Y, LU Q, CHEN HL.Diagnosis of primary liver cancer using lectin affinity chromatography of serum alkaline phosphatase[J].J Exp Clin Cancer Res, 1997, 16 (1) :75-80.

[22]ZHAO HZ, QI QG.Biochemical markers and HBV DNA levels in hepatitis B virus-related primary liver cancer patients with HBe Ag positive and HBe Ag negative[J/CD].Chin J Liver Dis:Electronic Edition, 2016, 8 (4) :87-90. (in Chinese) 赵海珍, 其其格.HBe Ag阳性及HBe Ag阴性乙型肝炎病毒相关原发性肝癌患者生物化学指标及病毒载量[J/CD].中国肝脏病杂志:电子版, 2016, 8 (4) :87-90.

[23]RECIPON G, PIVER E, CAILLE A, et al.Is procalcitonin increased in cases of invasive amoebiasis?A retrospective, observational study[J].Diagn Microbiol Infect Dis, 2015, 83 (4) :395-399.

[24]DABBOUS HK, ALI-ELDIN FA, MONTASSER IM.Role of procalcitonin in diagnosis of bacterial infection in trans-arterial chemoembolisation treated hepatocellular carcinoma patients[J].Arab J Gastroenterol, 2015, 16 (1) :10-13.

[25]YOU H, MA H, LIU T, et al.Different models of HBe Ag seroconversion predicated by on-treatment ALT and HBV DNA profiles[J].J Viral Hepat, 2009, 16 (12) :876-882.

施引文献

资源附件(0)

访问统计